Pfizer, one of the primary players in the Covid-19 vaccine manufacturing race, with over 2.5 billion doses administered, now has an antiviral pill to treat the infection. <br /> <br />The preliminary data of Pfizer's experimental antiviral pill to treat Covid-19 shows an 89 per cent decrease in the chance of hospitalisation or death for adults at risk of severe disease. Watch the video here to get the details.
